WHO WE ARE
CMR International, a Thomson Reuters business, is the most established and reputable source of pharmaceutical industry metrics and trends analysis in the world.
This enviable authority has been earned from almost 30 years at the heart of pharmaceutical development — talking with the world's largest and most important companies, understanding their pressures, needs and concerns, and accurately reflecting the shape of the industry throughout a period of unprecedented growth and unparalleled change.
Throughout this time, we've focused on one aim: to enhance the ability of pharmaceutical companies to develop vital new drugs quickly, cheaply and efficiently.
From challenging current practices to providing trusted performance metrics, we've supported the industry in making quicker, more informed decisions, improving efficiency, and promoting innovation.
In an industry where success depends ever more on objective, actionable data, CMR International is proud of its position as the knowledge provider that most of the world's leading companies rely on — and where quoting CMR International as a source of information is a universally-accepted guarantee of its validity.